Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Kim
Peter J Neumann

Showing results (271-280 of 438) with videos related to

Pageof 44
Sort By:
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
Pharmacoeconomics|June 16, 2011
A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policyJoseph Menzin, Lisa M Lines, Daniel E Weiner, et al.
Journal of Psychiatry & Neuroscience : JPN|June 28, 2019
Management of sexual adverse effects induced by atypical antipsychotic medicationLaura Downing, David D. Kim, Ric M. ` Procyshyn, et al.
Headache|October 17, 2017
New Onset Focal Stabbing Headache Associated With Peripheral Vertigo: A Case ReportTommy L H Chan, David D Kim, Werner J Becker
BMJ (Clinical Research Ed.)|February 24, 2006
Bias in published cost effectiveness studies: systematic reviewChaim M Bell, David R Urbach, Joel G Ray, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 16, 2021
Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness AnalysesNathaniel Hendrix, David D Kim, Krishna S Patel, et al.
Journal of Clinical Epidemiology|February 5, 2014
Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinomaDavid D Kim, Jean Y Tang, John P A Ioannidis
Pain Physician|November 17, 2011
Rates of lead migration and stimulation loss in spinal cord stimulation: a retrospective comparison of laminotomy versus percutaneous implantationDavid D Kim, Rakesh Vakharyia, Henry R Kroll, et al.
Journal of Applied Toxicology : JAT|June 24, 2004
Inhibition of topoisomerase II in 32D.3(G) cells by hydroquinone is associated with cell deathJacqueline Fung, Matthew J Hoffmann, David D Kim, et al.
Pharmacoeconomics|March 24, 2019
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease InterventionsPei-Jung Lin, Brittany D'Cruz, Ashley A Leech, et al.
Pageof 44

Showing results (271-280 of 438) with videos related to

Sort By:
Pageof 44
The Lancet. Infectious Diseases|May 28, 2005
A synthesis of cost-utility analysis literature in infectious diseasePatricia W Stone, Bruce R Schackman, Christopher P Neukermans, et al.
Pharmacoeconomics|June 16, 2011
A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policyJoseph Menzin, Lisa M Lines, Daniel E Weiner, et al.
Journal of Psychiatry & Neuroscience : JPN|June 28, 2019
Management of sexual adverse effects induced by atypical antipsychotic medicationLaura Downing, David D. Kim, Ric M. ` Procyshyn, et al.
Headache|October 17, 2017
New Onset Focal Stabbing Headache Associated With Peripheral Vertigo: A Case ReportTommy L H Chan, David D Kim, Werner J Becker
BMJ (Clinical Research Ed.)|February 24, 2006
Bias in published cost effectiveness studies: systematic reviewChaim M Bell, David R Urbach, Joel G Ray, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 16, 2021
Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness AnalysesNathaniel Hendrix, David D Kim, Krishna S Patel, et al.
Journal of Clinical Epidemiology|February 5, 2014
Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinomaDavid D Kim, Jean Y Tang, John P A Ioannidis
Pain Physician|November 17, 2011
Rates of lead migration and stimulation loss in spinal cord stimulation: a retrospective comparison of laminotomy versus percutaneous implantationDavid D Kim, Rakesh Vakharyia, Henry R Kroll, et al.
Journal of Applied Toxicology : JAT|June 24, 2004
Inhibition of topoisomerase II in 32D.3(G) cells by hydroquinone is associated with cell deathJacqueline Fung, Matthew J Hoffmann, David D Kim, et al.
Pharmacoeconomics|March 24, 2019
Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer's Disease InterventionsPei-Jung Lin, Brittany D'Cruz, Ashley A Leech, et al.
Pageof 44